Nxera Pharma Co Ltd (SOLTF)
9.724
-0.08
(-0.78%)
USD |
OTCM |
May 16, 16:00
Nxera Pharma Free Cash Flow: -49.09M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -49.09M |
| December 31, 2023 | -43.65M |
| September 30, 2023 | 5.990M |
| June 30, 2023 | 76.70M |
| March 31, 2023 | 78.72M |
| December 31, 2022 | 74.00M |
| September 30, 2022 | 123.65M |
| June 30, 2022 | 50.98M |
| March 31, 2022 | 57.35M |
| December 31, 2021 | 62.83M |
| September 30, 2021 | -4.787M |
| June 30, 2021 | 19.30M |
| March 31, 2021 | 20.68M |
| December 31, 2020 | 42.79M |
| September 30, 2020 | 12.35M |
| June 30, 2020 | 39.70M |
| March 31, 2020 | 40.05M |
| December 31, 2019 | 29.00M |
| September 30, 2019 | 13.86M |
| June 30, 2019 | -45.59M |
| March 31, 2019 | -64.65M |
| December 31, 2018 | |
| September 30, 2018 | -69.15M |
| June 30, 2018 | -45.98M |
| March 31, 2018 | -27.50M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.059M |
| September 30, 2017 | -8.421M |
| June 30, 2017 | -13.58M |
| March 31, 2017 | 115.81M |
| December 31, 2016 | 103.99M |
| September 30, 2016 | 144.85M |
| June 30, 2016 | 153.66M |
| March 31, 2016 | 36.18M |
| December 31, 2015 | 39.02M |
| September 30, 2015 | 10.72M |
| June 30, 2015 | 6.239M |
| March 31, 2015 | 0.0366M |
| December 31, 2014 | 0.3914M |
| September 30, 2014 | 9.580M |
| June 30, 2014 | 9.778M |
| March 31, 2014 | 3.522M |
| December 31, 2013 | 3.299M |
| September 30, 2013 | -8.253M |
| June 30, 2013 | -2.381M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 |
Free Cash Flow Range, Past 5 Years
-49.09M
Minimum
Mar 2024
123.65M
Maximum
Sep 2022
30.24M
Average
34.35M
Median
Free Cash Flow Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.633B |
| PeptiDream Inc | 6.450M |
| Healios KK | -19.34M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.86M |
| Cash from Investing (Quarterly) | -0.3369M |
| Cash from Financing (Quarterly) | -12.29M |
| Free Cash Flow Per Share (Quarterly) | -0.1698 |
| Free Cash Flow to Equity (Quarterly) | 28.29M |
| Free Cash Flow to Firm (Quarterly) | -15.19M |
| Free Cash Flow Yield | -5.98% |